Literature DB >> 10684357

Risk factors for hyperlipidemia in long-term pediatric renal transplant recipients.

D M Silverstein1, J Palmer, M S Polinsky, C Braas, S B Conley, H J Baluarte.   

Abstract

Hyperlipidemia (HL) is a common problem in adult renal transplant (TP) recipients, contributing to an increased risk of cardiovascular disease and chronic TP nephropathy. There are multiple causes of HL post renal TP in adult patients, including pre TP HL, immunosuppressive agents, renal dysfunction, hypoalbuminemia secondary to nephrotic syndrome, obesity, and conditions that lead to end-stage renal disease (ESRD). We evaluated the incidence and risk factors of HL in 62 pediatric renal TP recipients (15.4+/-4.2 years, range-3.0-22.3 years) with long-term (6.7+/-3.1 years) functioning [glomerular filtration rate (GFR) 66.7+/-23.2 ml/min per 1.73 m(2)] allografts. The mean serum cholesterol (C) level was 205. 5+/-43.6 mg/dl. Thirty-two patients (51.6%) exhibited elevated serum C levels. The mean serum triglyceride (TG) level was 157.3+/-88.4 mg/dl. Serum TG levels were elevated in 32 patients (51.6%). In patients with elevated serum levels of either C or TG, the mean low-density lipoprotein level (LDL) was 138.6+/-44.1 mg/dl (normal <130 mg/dl) and the high-density lipoprotein (HDL) level 54.6+/-15.9 mg/dl (normal>34 mg/dl). Of those patients studied, 45.5% had high LDL levels, whereas 9.1% exhibited low HDL levels. The two risk factors for elevated serum C levels in our patient population were pre-TP HL and increased years since TP. The only risk factor for elevated serum TG levels was reduced GFR. A family history of HL had a significant deleterious impact upon serum levels of C (P=0.01), but did not affect serum TG levels (P=0.7). Years on dialysis prior to TP, history of prior TP, gender, body mass index, and disease leading to ESRD had no influence upon the development of post-TP HL. We conclude that post-renal TP HL is a significant problem in pediatric renal TP recipients.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10684357     DOI: 10.1007/s004670050022

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  17 in total

Review 1.  Cardiovascular complications in pediatric end-stage renal disease.

Authors:  Rulan S Parekh; Samuel S Gidding
Journal:  Pediatr Nephrol       Date:  2004-12-15       Impact factor: 3.714

Review 2.  Assessing cardiovascular risk in children with chronic kidney disease. B-type natriuretic peptide: a potential new marker.

Authors:  Gema Ariceta; Ellen R Brooks; Craig B Langman
Journal:  Pediatr Nephrol       Date:  2005-08-05       Impact factor: 3.714

Review 3.  Dyslipidemia in children with CKD: should we treat with statins?

Authors:  Kjell Tullus
Journal:  Pediatr Nephrol       Date:  2011-04-13       Impact factor: 3.714

Review 4.  Vitamin E in renal therapeutic regiments.

Authors:  Mohamed Alaa Thabet; James C M Chan
Journal:  Pediatr Nephrol       Date:  2006-09-21       Impact factor: 3.714

5.  High plasma levels of oxidatively modified low-density lipoproteins are associated with the suppressed expression of immunomodulatory molecules in patients with hematological malignancies.

Authors:  Hai-Qing Yang; Fa-Qi Qiu; K E Jin; Neng-Gang Jiang; L I Zhang
Journal:  Exp Ther Med       Date:  2015-03-27       Impact factor: 2.447

6.  Effect of docosahexaenoic acid administration on plasma lipid profile and metabolic parameters of children with methylmalonic acidaemia.

Authors:  L Aldámiz-Echevarría; P Sanjurjo; J Elorz; J A Prieto; C Pérez; F Andrade; J Rodríguez-Soriano
Journal:  J Inherit Metab Dis       Date:  2006-02       Impact factor: 4.982

7.  Efficacy of simvastatin in children with hyperlipidemia secondary to kidney disorders.

Authors:  Silvestre García-de-la-Puente; José Luis Arredondo-García; Pedro Gutiérrez-Castrellón; Aurora Bojorquez-Ochoa; Edith Reyna Maya; María Del Pilar Pérez-Martínez
Journal:  Pediatr Nephrol       Date:  2009-02-24       Impact factor: 3.714

8.  Influence of diet on atherogenic risk in children with renal transplants.

Authors:  Luis Aldámiz-Echevarría; Alfredo Vallo; Pablo Sanjurjo; Javier Elorz; José Angel Prieto; José Ignacio Ruiz; Juan Rodríguez-Soriano
Journal:  Pediatr Nephrol       Date:  2004-07-16       Impact factor: 3.714

Review 9.  Cardiovascular disease in CKD in children: update on risk factors, risk assessment, and management.

Authors:  Amy C Wilson; Mark M Mitsnefes
Journal:  Am J Kidney Dis       Date:  2009-08       Impact factor: 8.860

10.  Serum lipid pattern unifies following renal transplantation in children.

Authors:  Thomas Müller; Silvie Koeppe; Klaus Arbeiter; Doris Luckner; Urike Salzer; Egon Balzar; Christoph Aufricht
Journal:  Pediatr Nephrol       Date:  2003-07-23       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.